Infection Surveillance Systems Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
The Global Infection Surveillance Systems Market Size accounted for USD 540 Million in 2022 and is estimated to achieve a market size of USD 2,097.5 Million by 2032 growing at a CAGR of 14.7% from 2023 to 2032.
Infection Surveillance Systems Market Highlights
- Global infection surveillance systems market revenue is poised to garner USD 2,097.5 million by 2032 with a CAGR of 14.7% from 2023 to 2032
- North America infection surveillance systems market value occupied almost USD 243 million in 2022
- Asia-Pacific infection surveillance systems market growth will record a CAGR of over 15% from 2023 to 2032
- Among type, the software sub-segment generated over US$ 383 million revenue in 2022
- Based on end-user, the hospitals sub-segment generated around 46% share in 2022
- Rising demand for infection surveillance systems due to the COVID-19 pandemic is a popular Infection Surveillance Systems market trend that fuels the industry demand
Hydroponics is a method of farming that provides better as well as higher yields than conventional agricultural methods. The two Natures of inputs such as nutrients and medium are used apart from the equipment in the overall system. Micronutrients and macronutrients are the major Natures of nutrients used. Developed countries in Europe such as Netherlands and France are engaged in the utilization of hydroponics farming in greenhouse cultivation. Moreover, Scandinavian countries also take use of the hydroponic method of farming as growing crops in the winter season is often tough. Exotic plants, which are not found in certain regions due to their climatic conditions, can be easily grown using the hydroponic method of farming. Thus, hydroponic makes all Natures of fruits and vegetables available in several countries around the year.
Global Infection Surveillance Systems Market Dynamics
Market Drivers
- Increasing prevalence of healthcare-associated infections (HAIs)
- Technological advancements in infection surveillance systems
- Growing awareness and focus on infection control and prevention measures in healthcare facilities
- Increasing government initiatives and regulations for infection control and prevention
Market Restraints
- High cost of installation, maintenance, and training associated with infection surveillance systems
- Lack of awareness and technical knowledge among farmers
- Lack of skilled professionals and expertise to manage and operate infection surveillance systems in healthcare facilities
- Data security concerns related to the use of infection surveillance systems
Market Opportunities
- Growing demand for cloud-based infection surveillance systems
- Increasing adoption of artificial intelligence and machine learning in infection surveillance systems
- Expansion of healthcare infrastructure in developing regions and increasing healthcare expenditure
- Partnerships and collaborations among companies to develop advanced infection surveillance solutions
Infection Surveillance Systems Market Report Coverage
| Market | Infection Surveillance Systems Market |
| Infection Surveillance Systems Market Size 2022 | USD 540 Million |
| Infection Surveillance Systems Market Forecast 2032 | USD 2,097.5 Million |
| Infection Surveillance Systems Market CAGR During 2023 - 2032 | 14.7% |
| Infection Surveillance Systems Market Analysis Period | 2020 - 2032 |
| Infection Surveillance Systems Market Base Year | 2022 |
| Infection Surveillance Systems Market Forecast Data | 2023 - 2032 |
| Segments Covered | By Type, By End-User, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Becton Dickson & Company, Baxter International, Premier, Inc., Truven Health Analytics Inc. (IBM Watson), Gojo Industries, Inc., RL Solutions, Wolters Kluwer N.V., VigiLanz Corporation, Atlas Medical (Roper Technologies), Quantros, Inc., BD Diagnostics, ICNet Systems, Inc. (Baxter International), Vecna Technologies, Inc., bioMerieux, Inc., Hygreen Inc., Emerald Health Information Systems Ltd., DEB Group Ltd., Iatric Systems, Inc., PeraHealth Inc., Cerner Corporation. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Infection Surveillance Systems Market Insights
The market is projected to rise significantly as key vendors are turning their attention towards innovation and the production of new and tailored products to boost sales. Moreover, rapid advancements in technology further ensure the expansion of the hydroponic farming system. For instance, a recently developed smartphone-operated plant growing system, Niwa is connected to the app and the internet. The system is easy to function, fully automated, and provides suitable conditions for growing variant crops.
Infection Surveillance Systems Market, By Segmentation
The worldwide market for infection surveillance systems is split based on nature, end-user, and geography.
Infection Surveillance System Types
- Software
- On-Premise
- Cloud
- Services
- Maintenance and Support
- Consultation and Training
- Implementation Service
According to the infection surveillance systems industry analysis, the software segment has shown significant growth due to the increasing demand for hospital-acquired infection surveillance software and microbial surveillance software in healthcare facilities worldwide. The software segment is expected to continue its dominance due to the advantages offered by these software such as real-time data tracking and analysis, easy integration with existing healthcare systems, and improved patient outcomes through early detection and prevention of infections.
The services segment has the potential to be one of the infection surveillance systems market's fastest-growing segments. While software is currently the market's dominant segment, demand for services is expected to rise in the coming years as healthcare facilities face challenges in implementing and maintaining infection surveillance systems.
Infection Surveillance System End-Users
- Hospitals
- Long-Term Care Facilities
- Clinics and Ambulatory Surgical Centers
- Other Healthcare Facilities
According to the infection surveillance systems market forecast, hospitals are the largest end-user of infection surveillance systems and are expected to maintain their market dominance. Because of the large number of patients, the frequent use of invasive medical procedures, and the close proximity of patients and healthcare workers, hospitals are the primary healthcare facilities that face the highest risk of acquiring and transmitting infections. Furthermore, hospitals are focusing more on infection control and prevention measures in order to reduce healthcare-associated infections (HAIs) and improve patient outcomes. As a result, hospitals are implementing advanced infection surveillance systems to improve infection control and prevention efforts. While long-term care facilities, clinics, and ambulatory surgical centres are important end-users of infection surveillance systems, they are smaller in size and have lower patient volumes, resulting in a lower demand for infection surveillance systems than hospitals.
Infection Surveillance Systems Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Infection Surveillance Systems Market Regional Analysis
The North American market for infection surveillance systems is currently the largest. The region's well-established healthcare infrastructure and the high prevalence of hospital-acquired infections are key drivers of market growth. The United States is the region's largest market, owing to an increased emphasis on infection prevention and control in hospitals and healthcare facilities.
The market for infection surveillance systems is predicted to grow significantly in the European region due to the rising prevalence of hospital-acquired infections and the rising uptake of cutting-edge medical technology. The region's well-established healthcare systems, as well as government initiatives to reduce healthcare-associated infections, are expected to drive market growth.
The Asia-Pacific region is expected to have the highest growth rate in the infection surveillance systems market due to rising healthcare expenditure and improved healthcare infrastructure in countries such as China, India, and Japan. Rising awareness of healthcare-associated infections, as well as increased adoption of advanced healthcare technologies, are expected to drive regional market growth.
Infection Surveillance Systems Market Players
Some of the top infection surveillance systems companies offered in the professional report include Becton Dickson & Company, Baxter International, Premier, Inc., Truven Health Analytics Inc. (IBM Watson), Gojo Industries, Inc., RL Solutions, Wolters Kluwer N.V., VigiLanz Corporation, Atlas Medical (Roper Technologies), Quantros, Inc., BD Diagnostics, ICNet Systems, Inc. (Baxter International), Vecna Technologies, Inc., bioMerieux, Inc., Hygreen Inc., Emerald Health Information Systems Ltd., DEB Group Ltd., Iatric Systems, Inc., PeraHealth Inc., Cerner Corporation.
Frequently Asked Questions
What was the market size of the global infection surveillance systems in 2022?
The market size of infection surveillance systems was USD 540 million in 2022.
What is the CAGR of the global infection surveillance systems market from 2023 to 2032?
The CAGR of infection surveillance systems is 14.7% during the analysis period of 2023 to 2032.
Which are the key players in the infection surveillance systems market?
The key players operating in the global infection surveillance systems market is includes Becton Dickson & Company, Baxter International, Premier, Inc., Truven Health Analytics Inc. (IBM Watson), Gojo Industries, Inc., RL Solutions, Wolters Kluwer N.V., VigiLanz Corporation, Atlas Medical (Roper Technologies), Quantros, Inc., BD Diagnostics, ICNet Systems, Inc. (Baxter International), Vecna Technologies, Inc., bioMerieux, Inc., Hygreen Inc., Emerald Health Information Systems Ltd., DEB Group Ltd., Iatric Systems, Inc., PeraHealth Inc., and Cerner Corporation.
Which region dominated the global infection surveillance systems market share?
North America held the dominating position in infection surveillance systems industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of infection surveillance systems during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global infection surveillance systems industry?
The current trends and dynamics in the infection surveillance systems industry include growing demand for cloud-based infection surveillance systems, increasing adoption of artificial intelligence and machine learning in infection surveillance systems, and expansion of healthcare infrastructure in developing regions and increasing healthcare expenditure.
Which type held the maximum share in 2022?
The software type held the maximum share of the infection surveillance systems industry.?
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
